🇺🇸 FDA
Drug

hydroxyurea

Brand: HYDROXYUREA

approved

Quick answer

hydroxyurea (HYDROXYUREA), is a pharmaceutical active ingredient, with approved status in the US.

Key facts

INN
hydroxyurea
Brand
HYDROXYUREA
Route
ORAL
Formulation
CAPSULE

Related patents

patent

US 6573300

Hydroxyurea treatment for spinal muscular atrophy

Expires Mon May 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Related news

FDA Approves Incyte's Jakafi XR Extended-Release Tablets for Myelofibrosis, Polycythemia Vera, and GVHD Treatment
NewsHematology/Oncology and ImmunologyMay 2, 2026

FDA Approves Incyte's Jakafi XR Extended-Release Tablets for Myelofibrosis, Polycythemia Vera, and GVHD Treatment

Incyte receives FDA approval for Jakafi XR (ruxolitinib) extended-release tablets, offering improved dosing convenience for rare blood disorders and GVHD patients.

Dr. Laura Bennett

Frequently asked questions

What is hydroxyurea?

hydroxyurea (HYDROXYUREA), is a pharmaceutical active ingredient, with approved status in the US.

What is the brand name for hydroxyurea?

HYDROXYUREA is a marketed brand name for hydroxyurea. Check FDA Drugs@FDA for the current US label holder.